Taken together, these studies demonstrate the correction of the FA/BRCA pathway through TALEN-mediated targeted integration of a therapeutic hFANCA cassette into the Mbs85 locus of FA-A MEFs. The gene discussed is FANCA; the disease is Friedreich ataxia.